The U.S. Food and Drug Administration has authorized the marketing of 20 ZYN nicotine pouch products through the premarket tobacco product application (PMTA) pathway. This approval signifies a regulatory milestone for synthetic nicotine products, which are designed to be placed between the gum and lip.
This decision reflects the agency's scientific review process and its efforts to regulate emerging nicotine delivery systems, aiming to balance innovation with public health safety.